Epidemiology

Higher dynamic medial knee load predicts greater cartilage loss over 12 months in medial knee osteoarthritis
Kim L Bennell, Kelly-Ann Bowles, Yuanyuan Wang, Flavia Cicuttini, Miranda Davies-Tuck, Rana S Hinman

Annals of the Rheumatic Diseases Oct 2011, 70 (10) 1770-1774; DOI: 10.1136/ard.2010.147082
Heart failure risk among patients with rheumatoid arthritis starting a TNF antagonist
Daniel H Solomon, Jeremy A Rassen, Bindee Kuriya, Lang Chen, Leslie R Harrold, David J Graham, James D Lewis, Joyce Lii, Liyan Liu, Marie R Griffin, J R Curtis

Annals of the Rheumatic Diseases Nov 2013, 72 (11) 1813-1818; DOI: 10.1136/annrheumdis-2012-202136
Childhood socioeconomic factors and perinatal characteristics influence development of rheumatoid arthritis in adulthood
Christine G Parks, Aimee A D'Aloisio, Lisa A DeRoo, Kirstin Huiber, Lisa G Rider, Frederick W Miller, Dale P Sandler

Annals of the Rheumatic Diseases Mar 2013, 72 (3) 350-356; DOI: 10.1136/annrheumdis-2011-201083
Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids
Marie B Condon, Damien Ashby, Ruth J Pepper, H Terence Cook, Jeremy B Levy, Megan Griffith, Tom D Cairns, Liz Lightstone

Annals of the Rheumatic Diseases Aug 2013, 72 (8) 1280-1286; DOI: 10.1136/annrheumdis-2012-202844
HLA-B27 and gender independently determine the likelihood of a positive MRI of the sacroiliac joints in patients with early inflammatory back pain: a 2-year MRI follow-up study
M van Onna, A G Jurik, D van der Heijde, A van Tubergen, L Heuft-Dorenbosch, R Landewé

Annals of the Rheumatic Diseases Nov 2011, 70 (11) 1981-1985; DOI: 10.1136/annrheumdis-2011-200025
Postmarketing surveillance of tocilizumab for rheumatoid arthritis in Japan: interim analysis of 3881 patients
Takao Koike, Masayoshi Harigai, Shigeko Inokuma, Naoki Ishiguro, Junnosuke Ryu, Tsutomu Takeuchi, Syuji Takei, Yoshiya Tanaka, Kyoko Ito, Hisashi Yamanaka

Annals of the Rheumatic Diseases Dec 2011, 70 (12) 2148-2151; DOI: 10.1136/ard.2011.151092
Risk factors for medial meniscal pathology on knee MRI in older US adults: a multicentre prospective cohort study
Martin Englund, David T Felson, Ali Guermazi, Frank W Roemer, Ke Wang, Michel D Crema, John A Lynch, Leena Sharma, Neil A Segal, Cora E Lewis, Michael C Nevitt

Annals of the Rheumatic Diseases Oct 2011, 70 (10) 1733-1739; DOI: 10.1136/ard.2011.150052
The degree of spinal inflammation is similar in patients with axial spondyloarthritis who report high or low levels of disease activity: a cohort study
U Kiltz, X Baraliakos, P Karakostas, M Igelmann, L Kalthoff, C Klink, D Krause, E Schmitz-Bortz, M Flörecke, M Bollow, J Braun

Annals of the Rheumatic Diseases Jul 2012, 71 (7) 1207-1211; DOI: 10.1136/annrheumdis-2011-200508
A tailored approach to reduce dose of anti-TNF drugs may be equally effective, but substantially less costly than standard dosing in patients with ankylosing spondylitis over 1 year: a propensity score-matched cohort study
Jakub Závada, Michal Uher, Katarína Sisol, Šárka Forejtová, Kateřina Jarošová, Heřman Mann, Jiří Vencovský, Karel Pavelka

Annals of the Rheumatic Diseases Jan 2016, 75 (1) 96-102; DOI: 10.1136/annrheumdis-2014-205202
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
Suzana Jordan, Jörg H W Distler, Britta Maurer, Dörte Huscher, Jacob M van Laar, Yannick Allanore, Oliver Distler

Annals of the Rheumatic Diseases Jun 2015, 74 (6) 1188-1194; DOI: 10.1136/annrheumdis-2013-204522

Main menu

Epidemiology

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Epidemiology

Pages